Eczema Trial Testing Oral Medication

Adults 18 years of age or older with eczema (atopic dermatitis) for at least 1 year, may qualify to participate. Individuals must have moderate to severe disease, involving at least 10% of their body surface area. A history (within 6 months) of inadequate response to treatment with medicated topical therapy, or who have required systemic therapies for control of their eczema, is also required.

Participants will receive investigational oral medication (active study drug), an active comparator via injection or placebo. Topical emollient will need to be applied to the skin, throughout the course of the study. Study medication and study-related care will be provided at no cost. Reimbursement for study-related expenses may be provided.

Study participation will last about 28 weeks and involve about 10 visits to the study centre.

Call the study centre near you, or register now.

Learn more about
Atopic Dermatitis
Register Now!

Register for
Active Studies!

Register

All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more